We found that SRC-1 was up-regulated in thyroid cancer tissues and interacted with NF-kB signals to promote VEGFC expression and increase the numbers of LYVE-positive lymphatic vessels. The gene discussed is SRC; the disease is thyroid gland carcinoma.